Global Biobanking Market Overview:
Global Biobanking Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2025-2032, Considering the Base Year As 2024.
Global Biobanking Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Biobanking involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Biobanking Market:
The Biobanking Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Biobanking Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Biobanking Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Biobanking market has been segmented into:
Equipment
Consumables
Services
Software
By Application, Biobanking market has been segmented into:
Blood Products
Human Tissues
Nucleic Acids
Cell Lines
Biological Fluids
Human Waste Products
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Biobanking market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Biobanking market.
Top Key Players Covered in Biobanking market are:
Hamilton Company
Greiner Holding AG
Promega Corporation
Becton
Dickinson
and Company
Merck KGaA
VWR Corporation
Tecan Trading AG
Thermo Fisher Scientific Inc.
Panasonic Healthcare Holdings Co.
Ltd.
Qiagen N.V.
Brooks Automation Inc.
Chart Industries Inc.
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Biobanking Market Type
4.1 Biobanking Market Snapshot and Growth Engine
4.2 Biobanking Market Overview
4.3 Equipment
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Equipment: Geographic Segmentation Analysis
4.4 Consumables
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Consumables: Geographic Segmentation Analysis
4.5 Services
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Services: Geographic Segmentation Analysis
4.6 Software
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Software: Geographic Segmentation Analysis
Chapter 5: Biobanking Market Application
5.1 Biobanking Market Snapshot and Growth Engine
5.2 Biobanking Market Overview
5.3 Blood Products
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Blood Products: Geographic Segmentation Analysis
5.4 Human Tissues
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Human Tissues: Geographic Segmentation Analysis
5.5 Nucleic Acids
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Nucleic Acids: Geographic Segmentation Analysis
5.6 Cell Lines
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Cell Lines: Geographic Segmentation Analysis
5.7 Biological Fluids
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.7.3 Biological Fluids: Geographic Segmentation Analysis
5.8 Human Waste Products
5.8.1 Introduction and Market Overview
5.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.8.3 Human Waste Products: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Biobanking Market Share by Manufacturer (2023)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 HAMILTON COMPANY
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 GREINER HOLDING AG
6.4 PROMEGA CORPORATION
6.5 BECTON
6.6 DICKINSON
6.7 AND COMPANY
6.8 MERCK KGAA
6.9 VWR CORPORATION
6.10 TECAN TRADING AG
6.11 THERMO FISHER SCIENTIFIC INC.
6.12 PANASONIC HEALTHCARE HOLDINGS CO.
6.13 LTD.
6.14 QIAGEN N.V.
6.15 BROOKS AUTOMATION INC.
6.16 CHART INDUSTRIES INC.
Chapter 7: Global Biobanking Market By Region
7.1 Overview
7.2. North America Biobanking Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Equipment
7.2.2.2 Consumables
7.2.2.3 Services
7.2.2.4 Software
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Blood Products
7.2.3.2 Human Tissues
7.2.3.3 Nucleic Acids
7.2.3.4 Cell Lines
7.2.3.5 Biological Fluids
7.2.3.6 Human Waste Products
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Biobanking Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Equipment
7.3.2.2 Consumables
7.3.2.3 Services
7.3.2.4 Software
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Blood Products
7.3.3.2 Human Tissues
7.3.3.3 Nucleic Acids
7.3.3.4 Cell Lines
7.3.3.5 Biological Fluids
7.3.3.6 Human Waste Products
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Biobanking Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Equipment
7.4.2.2 Consumables
7.4.2.3 Services
7.4.2.4 Software
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Blood Products
7.4.3.2 Human Tissues
7.4.3.3 Nucleic Acids
7.4.3.4 Cell Lines
7.4.3.5 Biological Fluids
7.4.3.6 Human Waste Products
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Biobanking Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Equipment
7.5.2.2 Consumables
7.5.2.3 Services
7.5.2.4 Software
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Blood Products
7.5.3.2 Human Tissues
7.5.3.3 Nucleic Acids
7.5.3.4 Cell Lines
7.5.3.5 Biological Fluids
7.5.3.6 Human Waste Products
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Biobanking Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Equipment
7.6.2.2 Consumables
7.6.2.3 Services
7.6.2.4 Software
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Blood Products
7.6.3.2 Human Tissues
7.6.3.3 Nucleic Acids
7.6.3.4 Cell Lines
7.6.3.5 Biological Fluids
7.6.3.6 Human Waste Products
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Biobanking Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Equipment
7.7.2.2 Consumables
7.7.2.3 Services
7.7.2.4 Software
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Blood Products
7.7.3.2 Human Tissues
7.7.3.3 Nucleic Acids
7.7.3.4 Cell Lines
7.7.3.5 Biological Fluids
7.7.3.6 Human Waste Products
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Biobanking Scope:
|
Report Data
|
Biobanking Market
|
|
Biobanking Market Size in 2025
|
USD XX million
|
|
Biobanking CAGR 2025 - 2032
|
XX%
|
|
Biobanking Base Year
|
2024
|
|
Biobanking Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Hamilton Company, Greiner Holding AG, Promega Corporation, Becton, Dickinson, and Company, Merck KGaA, VWR Corporation, Tecan Trading AG, Thermo Fisher Scientific Inc., Panasonic Healthcare Holdings Co., Ltd., Qiagen N.V., Brooks Automation Inc., Chart Industries Inc..
|
|
Key Segments
|
By Type
Equipment
Consumables
Services
Software
By Applications
Blood Products
Human Tissues
Nucleic Acids
Cell Lines
Biological Fluids
Human Waste Products
|
